Navigation Links
A realistic look at the promises and perils of nanomedicine
Date:11/16/2011

Is the emerging field of nanomedicine a breathtaking technological revolution that promises remarkable new ways of diagnosing and treating diseases? Or does it portend the release of dangerous nanoparticles, nanorobots or nanoelectronic devices that will wreak havoc in the body? A new review of more than 500 studies on the topic concludes that neither scenario is likely. It appears in ACS' journal Molecular Pharmaceutics.

Ruth Duncan and Rogerio Gaspar explain that nanomedicine - the application of nanotechnology to health care -often is overhyped as cure-alls or a potential danger. The concept debuted with the visionary notion that robots and electronic devices so tiny that dozens would fit across the width of a human hair could be built and put into the human body to treat disease and repair damaged organs. About 40 nano health care products actually are in use and nano-sized drugs, drug delivery devices, imaging agents, and other products are on the horizon.

The authors first describe the history of nanomedicine, as well as many of the nanomedicine products available today. Then, they offer suggestions for how best to move a nanomedicine through the drug development process with risks and benefits in mind. Finally, they identify key factors critical for development of practical nanomedical technology that is safe and effective.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Realistic Activity Goals Seem to Ease Arthritis Pain, Study Finds
2. Achieving realistic physical activity goals benefits RA patients
3. Magical thinking helps dieters cope with unrealistic expectations
4. UK Government plans for mentally ill prisoners are unrealistic, research suggests
5. Promise of genomics research needs a realistic view
6. Unrealistic optimism appears common in early cancer trials
7. System uses electrical trickery on the brain to induce realistic spaceflight effects
8. Realistic Physical Goals Can Make You a Winner
9. New UC research promises better collection of prostate cancer cells
10. New Pill Promises to Stop Gray Hair
11. Will Redmond ONeal Fulfill His Mothers Wishes? Promises Addiction Guru Dr. David Sack Weighs In.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... Japanese Zen ... Yoga Mat Revolution” on 6th, 7th and 8th October at Miranda Kuo Gallery on ... mat art pieces, such as Zen Kodo mat. Wanderlust , one of the ...
(Date:9/21/2017)... Boulder, CO (PRWEB) , ... September 21, 2017 ... ... Education Interview of the Month, Lewis and Clark College Emeritus Professor of Education ... Associate Faith Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... voice for people who have kidney disease. The theme “Describe a positive decision ... stories. Entrants needed to meet only one qualification— to have been diagnosed ...
(Date:9/20/2017)... ... September 20, 2017 , ... Announced ... Aligner clinical and commercial support services market) has entered into an agreement on ... Australia. , The PGSD is the first private Dental School to launch ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Honey Pot ... Vaginas.” The goal is to ignite conversation via social media and word-of-mouth regarding ... brand has declared September “Humans with Vaginas” month, releasing a video celebrating the ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: